248 related articles for article (PubMed ID: 1913692)
1. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.
Ishikawa J; Xu HJ; Hu SX; Yandell DW; Maeda S; Kamidono S; Benedict WF; Takahashi R
Cancer Res; 1991 Oct; 51(20):5736-43. PubMed ID: 1913692
[TBL] [Abstract][Full Text] [Related]
2. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.
Dodson MK; Cliby WA; Xu HJ; DeLacey KA; Hu SX; Keeney GL; Li J; Podratz KC; Jenkins RB; Benedict WF
Cancer Res; 1994 Feb; 54(3):610-3. PubMed ID: 8306318
[TBL] [Abstract][Full Text] [Related]
3. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
4. Expression of the retinoblastoma gene product in renal tumors.
Presti JC; Reuter VE; Cordon-Cardo C; Motzer RJ; Albino AP; Jhanwar SC; Nanus DM
Anticancer Res; 1996; 16(2):549-56. PubMed ID: 8687097
[TBL] [Abstract][Full Text] [Related]
5. Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.
Zhang X; Xu HJ; Murakami Y; Sachse R; Yashima K; Hirohashi S; Hu SX; Benedict WF; Sekiya T
Cancer Res; 1994 Aug; 54(15):4177-82. PubMed ID: 8033150
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma.
Cairns P; Proctor AJ; Knowles MA
Oncogene; 1991 Dec; 6(12):2305-9. PubMed ID: 1766677
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity at the p53, RB, DCC and APC tumor suppressor gene loci in human bladder cancer.
Miyamoto H; Shuin T; Ikeda I; Hosaka M; Kubota Y
J Urol; 1996 Apr; 155(4):1444-7. PubMed ID: 8632608
[TBL] [Abstract][Full Text] [Related]
9. The retinoblastoma gene is involved in malignant progression of astrocytomas.
Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
[TBL] [Abstract][Full Text] [Related]
11. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.
Yoo GH; Xu HJ; Brennan JA; Westra W; Hruban RH; Koch W; Benedict WF; Sidransky D
Cancer Res; 1994 Sep; 54(17):4603-6. PubMed ID: 8062250
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer.
Semczuk A; Marzec B; Roessner A; Jakowicki JA; Wojcierowski J; Schneider-Stock R
Virchows Arch; 2002 Dec; 441(6):577-83. PubMed ID: 12461615
[TBL] [Abstract][Full Text] [Related]
13. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ
Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities and the implication of retinoblastoma locus and its protein product in head and neck cancers.
Yokoyama J; Shiga K; Sasano H; Suzuki M; Takasaka T
Anticancer Res; 1996; 16(2):641-4. PubMed ID: 8687109
[TBL] [Abstract][Full Text] [Related]
16. Molecular and immunochemical analyses of RB1 and cyclin D1 in human ductal pancreatic carcinomas and cell lines.
Huang L; Lang D; Geradts J; Obara T; Klein-Szanto AJ; Lynch HT; Ruggeri BA
Mol Carcinog; 1996 Feb; 15(2):85-95. PubMed ID: 8599583
[TBL] [Abstract][Full Text] [Related]
17. Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation.
Goodrich DW; Chen Y; Scully P; Lee WH
Cancer Res; 1992 Apr; 52(7):1968-73. PubMed ID: 1551125
[TBL] [Abstract][Full Text] [Related]
18. Changes in growth and tumorigenicity following reconstitution of retinoblastoma gene function in various human cancer cell types by microcell transfer of chromosome 13.
Banerjee A; Xu HJ; Hu SX; Araujo D; Takahashi R; Stanbridge EJ; Benedict WF
Cancer Res; 1992 Nov; 52(22):6297-304. PubMed ID: 1423276
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of cancer suppression by the retinoblastoma gene.
Lee WH
Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma.
Walther MM; Gnarra JR; Elwood L; Xu HJ; Florence C; Anglard P; Hu SX; King C; Trahan E; Hurley K
J Urol; 1995 Jun; 153(6):2050-4. PubMed ID: 7752392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
